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Abstract
There are numerous studies describing the signaling mechanisms that mediate oligodendrocyte precursor cell (OPC)
proliferation and differentiation, although the contribution of the cellular prion protein (PrPc) to this process remains
unclear. PrPc is a glycosyl-phosphatidylinositol (GPI)-anchored glycoprotein involved in diverse cellular processes during the
development and maturation of the mammalian central nervous system (CNS). Here we describe how PrPc influences
oligodendrocyte proliferation in the developing and adult CNS. OPCs that lack PrPc proliferate more vigorously at the
expense of a delay in differentiation, which correlates with changes in the expression of oligodendrocyte lineage markers. In
addition, numerous NG2-positive cells were observed in cortical regions of adult PrPc knockout mice, although no
significant changes in myelination can be seen, probably due to the death of surplus cells.
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Introduction
Oligodendrocyte maturation and differentiation is a well-
orchestrated process that has been studied in detail in isolated
oligodendrocyte precursor cells (OPCs) in culture, where the
proliferation and differentiation of OPCs is controlled by a well-
defined sequence of events (see for example, [1,2]). In recent years,
numerous studies have sought to identify new factors that regulate
OPC proliferation and differentiation (see [3,4,5] for reviews).
During development, immature proliferative oligodendrocytes are
characterized by the expression of the chondroitin sulphate
proteoglycan, NG2, together with other markers, such as the
platelet-derived growth factor receptor alpha (PDGFr-a) and the
cell surface ganglioside A2B5 antigen [5,6,7,8,9,10]. During
maturation, oligodendrocytes sequentially express markers such
as adenomatous polyposis coli (APC-CC1) and 2’,3’-cyclic
nucleotide 3’-phosphodiesterase (CNPase), as well as markers of
myelinating oligodendrocytes, such as myelin basic protein (MBP)
and myelin-associated glycoprotein (MAG). Other antigens of the
oligodendrocyte lineage, such as the helix-loop-helix transcription
factors Olig2 and Sox10, are expressed in immature as well as
mature myelinating oligodendrocytes [11]. In the adult brain, the
OPCs that persist are considered to be a putative reservoir of
mature oligodendrocytes. These cells proliferate and differentiate
into myelinating oligodendrocytes in order to maintain myelin in
both the healthy and injured brain [9,12,13,14,15,16,17,18,19].
Adult OPCs in the neuronal parenchyma are NG2-positive (see
[20] for review) and they are considered to be cycling cells with the
capacity to differentiate into mature oligodendrocytes, as well as
protoplasmic astrocytes [15] and neurons [13,21].
The process of myelination is influenced by many factors,
including EGFr-mediated signaling [22]. EGFr signaling is a
complex process that is dependent upon trans-activation by other
membrane-associated proteins or receptors (e.g., GPCRs) [23].
Molecules or receptors previously thought to be unrelated to
EGFr-mediated signaling have recently been characterized as
putative modulators of EGFr pathways. One example in the CNS
is the cellular prion protein (PrPc), a glycosyl phosphatidyl inositol
(GPI)-anchored cell surface protein encoded by the Prnp gene
[24,25,26,27]. Clustering of PrPc at the cell surface has been
shown to modulate EGFr activity in GT1-7 cells [28], and while
the developmental functions of PrPc remain to be fully determined,
PrPc may help maintain myelin in both the CNS and the
peripheral nervous system (PNS) [29]. However, a putative link
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between PrPc and OPC proliferation or oligodendrocyte differen-
tiation in the CNS has not yet been fully determined.
Accordingly, we have analyzed how PrPc might influence the
proliferation and differentiation of embryonic OPCs and of adult
NG2 expressing cells. We isolated OPCs from diverse origins and
developmental stages, and analyzed their distribution in the
forebrain of adult Prnp0/0 and Prnp+/+ mice. The absence of PrPc
increased the number of undifferentiated oligodendrocytes and
delayed the expression of differentiation markers in vitro (e.g., Sox17,
cdk2, APC, CNPase). In accordance with these in vitro findings, the
large numbers of cells expressing Olig2 and NG2 were evident in
the cortical parenchyma of developing and adult mice. Surpris-
ingly, the increase in the number of NG2 expressing cells was not
correlated with alterations in myelination, suggesting that
compensatory mechanisms may have offset this effect. Indeed,
the number of BrdU-labeled OPCs in the Prnp0/0 cortex two weeks
after pulse labeling decreased significantly to wild-type level. This
decrease was correlated with the appearance of TUNEL labeling
in the NG2 expressing cells, suggesting that surplus OPCs are
eliminated by cell death in the adult Prnp0/0 cortex.
Methods
Mice
Prnp0/0 Zu¨rich-1 mice were purchased from EMMA (Monter-
otondo, Italy) and they carried approximately 46.8% C57BL/6J
microsatellite markers (Charles River Laboratories). To avoid
putative background-related differences, we backcrossed our
Prnp0/0 mice with C57BL/6J mice over several generations. All
experiments were carried out using littermates derived from
selected heterozygous (Prnp0/+) parents after backcrossing (50
littermates: 34 adult mice and 16 newborn mice). The presence of
C57BL/6J markers in all the mouse phenotypes used in the
present study was determined by the Genetic testing service at
Charles River Laboratories, analyzing 110 microsatellite markers
at approximately 15 cM intervals across the 19 autosomes and the
X chromosome. This analysis distinguishes between 129 micro-
satellite markers ranging from 92 to 95% of C57BL/6J. For
genotyping, the following specific primers for Prnp0/0 (Zu¨rich I)
were designed [30]: P10-new: 59-cataatcagtggaacaagccc-39; P4-
new: 59-gctacaggtggataacccctc-39; P3-new: 59-gccttctatcgccttctt-
gac-39. PCR was performed over 40 cycles: 4 minutes at 95uC; 4
minutes at 62uC and 1 minute at 72uC; followed by a final
extension for 5 minutes at 72uC. We did not analyze the behavior
of OPCs in mice overexpressing PrPc (e.g., Tga20), as differences in
PrPc expression have been reported in these animals when
compared to wild type mice [31,32]. All studies were performed
under the guidelines and protocols of the Ethical Committee for
Animal Experimentation (CEEA) at the University of Barcelona,
and the protocol for the use of animals in this study was reviewed
and approved by the CEEA at the University of Barcelona (CEEA
approval# 115/11).
Antibodies
The following antibodies were used to detect OPCs: rabbit anti-
NG2 and anti-Olig2 (1:200: Chemicon, Temecula, CA, USA),
mouse monoclonal anti-A2B5 (1:10, mAb 4D4: Developmental
Studies Hybridoma Bank-DSHB, University of Iowa, USA), and
anti-Nestin (1:1000: Chemicon). To detect mature oligodendro-
cytes and myelin we used a rabbit antiserum against CNPase
(1:200: Thermo Scientific, Fremont, USA) or MAG (1:1000: Santa
Cruz biotechnology, Santa Cruz, USA), or a mouse monoclonal
against MBP (1:2000: Chemicon). To detected astrocytes and
neurons, we used a mouse monoclonal against GFAP (1:500: Dako
Glostrup, Denmark) and NeuN (1:50: Chemicon), respectively.
Proliferating cells were detected using a rat monoclonal antibody
raised against BrdU (1:50: Harlan Sera-Lab, Loughborough,
England). To probe western blots, a mouse monoclonal antibody
against actin (1:10000) or tubulin (1:1000; Chemicon) were also
used. Two different mouse monoclonal antibodies were used to
detect PrPc: SAF61 (1:1000: Spi-Bio & Cayman Chemical, Massy
Cedex, France) and 6H4 (1:200: Prionics, Schlieren, Switzerland).
Embryonic Optic Nerve Cultures
The embryonic optic nerves (ONs) from E16.5 embryos were
dissected out and cultured as described previously [33,34]. Briefly,
ON explants were placed in three-dimensional gels of rat tail-
derived collagen and cultured in Bottenstein-Sato medium
supplemented with FGF-2 (20 ng/ml: R&D Systems, Minneapo-
lis, USA) at 37uC, in an atmosphere of 5% CO2 and at 95%
humidity. After 3 days in vitro (DIV), genotypically identified
cultures were fixed with 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffered saline (PBS, pH 7.4). The number of cells
migrating out of the explants was counted and the maximum
distance migrated with respect to the center of the ON explants
was determined. Cell proliferation was assessed by BrdU
incorporation (50 mM: Sigma-Aldrich, Poole Dorset, UK) added
to the medium for 6 hours (from 42–48 hours post-culture) as
described previously [35]. The medium was then removed and the
cultures were fixed as described above.
Cortical OPC Purification
Primary cultures were prepared from Prnp0/0 and Prnp+/+ mouse
pups (P0–P2) as described previously [36,37]. Cortical tissue was
dissected out and digested at 37uC with trypsin and DNAse
(Sigma-Aldrich) in HBSS (without Ca2+ and Mg2+). After
centrifugation, the cells were resuspended in 10 ml of DMEM
containing 10% fetal bovine serum and antibiotics (DMEM
medium). This suspension was then filtered through 100 mm filters
and the cells were seeded in 75 ml flasks and 6-well culture plates
previously coated with poly-L-ornithine (Sigma-Aldrich), changing
the medium every three days. To obtain differentiated cells, once
80–90% confluence was reached the medium was switched to
serum free DMEM medium supplemented with T3, T4,
putresceine, progesterone and sodium selenite (SFM; all from
Sigma-Aldrich). These cells were then maintained for 5 DIV to
allow them to differentiate into mature oligodendrocytes. As cell
death in Prnp0/0-cultured cells augments after serum removal
[38,39], OPCs were cultured over a feed layer of astrocytes for
5 days (mixed cultures). Cultures were then processed to obtain
purified oligodendrocytes. Thus, cultures were shaken at
250 r.p.m. overnight at 37uC, and the medium was then filtered
through 40 mm filters and centrifuged at 800 r.p.m for 5 minutes.
The pellet containing the OPCs was analyzed by RT-qPCR or
Western blotting. However, both Prnp0/0 and Prnp+/+ derived
OPCs were cultured in parallel.
To analyze a putative influence of astrocytes in the behavior
of OPCs, when the cultures reached 80–90% confluence in
DMEM medium they were shaken to purify the OPCs as
described above (isolated cultures). The isolated OPCs were
then cultured in SFM for additional 5 DIV and their
differentiation, survival and proliferation in the absence of
astrocytes was analyzed. In addition, we also obtained RNA for
RT-qPCR from these purified cells as described above for the
mixed cultures. Lastly, freshly shaked OPCs isolated cultures
from Prnp+/+ and Prnp0/0 mixed cultures were treated with
different concentrations of conditioned medium (DMEM)
derived from cultured astrocytes from the opposite genotype.
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After 5 DIV, treated cultures were fixed, double labeled using
CNPase and Olig2 antibodies and quantified.
Neurosphere Isolation and Differentiation in vitro
To prepare neurospheres, Prnp0/0 and Prnp+/+ P5 pups were
anaesthetized by hypothermia and their brains were removed from
the skull aseptically. The subventricular zone of the lateral
ventricle was dissected in cold HBSS (without Ca2+ or Mg2+),
and the cells were cultured and differentiated as described
previously [40], in culture medium supplemented with B27,
antibiotics, FGF-2 and EGF (20 ng/ml, Sigma-Aldrich: unless
otherwise indicated, all culture media and supplements were
purchased from GIBCO Life Technologies, Merelbeke, Belgium).
Growing spheres were mechanically dissociated each week and
plated in fresh medium (1 passage/week). In the differentiation
experiments, after mitogen withdrawal neurospheres were grown
on poly-L-ornithine and laminin (Sigma-Aldrich) coated coverslips
(12 mm) for 7 days in serum-free medium (DMEM containing
glutamine, B27 and antibiotics). After differentiation, the cultures
were fixed with 2% paraformaldehyde for 1 hour at 4uC and they
were then processed for immunocytochemistry with Alexa-Fluor
488 and 546 tagged secondary antibodies (Molecular Probes,
Eugene, USA). After rinsing, the cell nuclei were counterstained
for 10 minutes with DAPI (1 mM in 0.1 M PBS) and the cells were
mounted in FluoromountTM (Vector Labs, Burlingame, USA).
The cells were examined on an Olympus BX61 or an Olympus
Fluoview SV 500 confocal microscope, obtaining images in
sequential scanning laser mode to avoid fluorochrome cross-
excitation.
Tissue Homogenates and Western Blotting
Mouse tissue was homogenized in lysis buffer (50 mM Tris/HCl
pH 7.4, 150 mM NaCl, 1% Triton X-100, 1.5 mM MgCl2, 10%
glycerol, 1 mM PMSF and protease inhibitors) and centrifuged at
15,000 r.p.m for 30 minutes at 4uC. Supernatants containing
soluble protein were quantified using the BCA assay (Pierce,
Rockford, USA) and the total cell protein extract (50 mg) was
mixed with Laemmli sample buffer, boiled at 100uC for 10
minutes and run on 8–12% SDS-PAGE gels. The proteins were
transferred to PVDF membranes that were then probed with the
corresponding antibodies at the concentrations indicated. Anti-
body binding was visualized by enhanced chemiluminescence
(ECL, Amersham-Pharmacia) and monoclonal antibodies against
actin and tubulin were used to normalize for loading.
Immunohistochemistry
The day of detecting the vaginal plug in female Prnp+/0 mice
was considered as embryonic day 0.5 (E0.5) and the day of birth
(the night between E19 and E20) was considered postnatal day 0
(P0). Animals were sacrificed on either E16.5 or upon reaching 2
months of age (adults). Three to five animals from at least 3
different litters of different genotypes were processed after genomic
identification. Fetuses were removed by caesarean section and all
the animals were transcardially perfused with 4% PFA. After
perfusion, the brain was removed from the skull and post-fixed in
4% PFA for 12 hours, cryoprotected in 30% sucrose and sectioned
on a cryostat at a thickness of 20 (embryos) or 30 mm (adults). The
sections were permeabilized with 0.1 M PBS containing 0.2%
Triton X-100 and to avoid unwanted cross-reactivity with the
immunoreagents they were then blocked with 10% normal goat
serum containing anti-mouse or anti-rabbit Fab fragments (1:50:
Jackson ImmunoResearch, West Grove, USA). Subsequently, the
sections were incubated overnight at 4uC with the primary
antibodies (NG2, Olig2, etc) and the primary antibodies bound to
the tissue were detected using the avidin-biotin peroxidase
complex (ABC), according to the manufacturer’s instructions
(Vector Laboratories), or with Alexa-Fluor 488 and 546
conjugated secondary antibodies (Molecular Probes, Eugene,
USA). For the ABC method, immunoreagents were diluted in
0.1 M PBS containing 0.5% Triton X-100, 0.2% gelatin and 5%
pre-immune serum. After development with 0.03% diaminoben-
zidine (DAB) and 0.01% H202, sections were mounted on
gelatinized slides, dehydrated in ethanol and coverslipped with
EukittTM (Merck Chemicals, Darmstadt, Germany). For immu-
nofluorescence, sections were counterstained with DAPI and
mounted in FluoromountTM (Vector Labs). Omission of the
primary antibody or its substitution with normal serum in the
immunocytochemical controls yielded no immunostaining.
In situ Hybridization
To detect MAG expression, we generated a cRNA probe that
recognizes both S-MAG and L-MAG [41]. A 760 bp restriction
fragment (base pairs 885–1645, shared by both S- and L-MAG)
was obtained by digesting the full-length cDNA with EcoRI and
XhoI and it was cloned into pBlueScript SK+. A MAG antisense
probe was generated from this plasmid by linearization with
EcoRI, followed by in vitro transcription with T7 RNA polymerase.
Conversely, a MAG sense probe was generated by linearization
with XhoI followed by transcription with T3 RNA polymerase.
Both sense and anti-sense riboprobes were labeled with digox-
igenin according to the manufacturer’s instructions (Roche Farma,
Barcelona, Spain), and in situ hybridization was carried out as
described previously [41].
BrdU-pulse Labeling and Immunohistochemistry
For BrdU labeling, 2 month old mice (Prnp0/0 or Prnp+/+)
received a daily i.p. pulse of BrdU (50 mg/kg b.w.) on 4 days (see
[40] for details). BrdU-injected mice were assigned to 2 equivalent
experimental groups and sacrificed 1 (4 + 1) or 15 (4 + 15) days
after the last BrdU injection. Mice were perfused with 4% PFA
and post-fixed in the same fixative for an additional 2.5 hours at
4uC. After fixation, the brains of the mice were cryoprotected,
frozen and microtome sections were obtained (30 mm). Free-
floating sections were processed as described previously [42].
Briefly, sections were pre-treated with cold 0.1 N HCl for 15
minutes and 2 N HCl for 20 minutes at 37uC to denature the
DNA. After rinsing in 0.1 M PBS, the sections were incubated
with a Fab goat anti-mouse IgG (1:50, Jackson ImmunoResearch)
for 2 hours and then with the anti-BrdU antibody. The binding of
the primary antibody to the tissue was detected using a
biotinylated secondary antibody and the ABC method. Alternative
serial sections were stained with cresyl violet or processed for dual
immunofluorescence detection of BrdU using Alexa-Fluor 488 and
Alexa-Fluor 568 tagged secondary antibodies (Molecular Probes)
as indicated [43]. Finally, the sections were mounted in
FluoromountTM (Vector Labs).
RT-qPCR
Quantitative real time PCR was performed on total RNA
extracted from isolated oligodendrocytes with the mirVana’s
isolation kit (Ambion) according to the manufacturer’s instruc-
tions. Purified RNAs were used to generate the corresponding
cDNAs that served as PCR templates for mRNA quantification.
The following primers were used for RT-qPCR validation: Prnp
For: 59-agtcgttgccaaaatggatca-39; Prnp Rev: 5`-aaccaacctcaag-
catgtgg-39; Olig2 For: 59-ctggtgtctagtcgcccatc-39; Olig2 Rev: 59-
gctcagtcatctgcttct-39; NG2 For: 59-agcacgatgactctgagacc-39; NG2
Rev: 59-ggctacgtgaagataggg-39; Sox10 For: 59-cggacgatga-
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caagttcccc-39; Sox10 Rev: 59-gaggtgagggtactggtcg-39; Nkx2.2 For:
59-ggtggagcgattggataaga-39; Nkx2.2 Rev: 59-tgccatcaaccttttcatca-
39; CNPase For: 59-cagctcaaggagaagaacc-39; CNPase Rev: 59-
ttgtacagtgcagcacacc-39; APC For: 59-gaagtcagtcggcatctaaagga-39;
APC Rev: 59-tctccaagtactcactcgagg-39. Sox17 For: 59-
ctttatggtgtgggccaaag-39; Sox17 Rev: 59-cttctctgccaaggtcaacg-39;
cdk2 Rev: 59-cctgcttatcaatgcagaggg-39; cdk2 Rev: 59-tgcgggtcac-
catttcagc-39. PCR amplification and detection was performed on a
Roche LightCycler 480 detector, using the 2x Sybr Green Master
Mix (Roche) as the reagent according to the manufacturer’s
instructions. The reaction protocol involved a denaturation-
activation cycle (95uC for 10 minutes), followed by 40 cycles of
denaturation-annealing-extension (95uC for 10 minutes, 72uC for
1 minute, 98uC continuous). The mRNA levels were calculated
using the LightCycler 480 software and the data was analyzed
using the DDCt method. Both experimental and calibration
samples were normalized to the relative expression of a
housekeeping gene (GAPDH).
Results
Impaired Proliferation and Differentiation of
Hippocampal Progenitor Cells in PrPc Knockout Mice
PrPc expression was previously shown to enhance the
proliferation of SVZ-derived stem cells, whilst in its absence the
proliferation of hippocampal progenitors in the subgranular zone
(SGZ) was impaired [44]. More recently, PrPc was shown to play a
critical role in modulating the proliferation of cells in embryonic-
derived neurospheres [45]. Thus, we sought to corroborate these
results in our backcrossed Prnp0/0 mice. Cell proliferation and
neurogenesis in the dentate gyrus of Prnp0/0 and Prnp+/+ mice was
monitored by measuring BrdU incorporation into dividing cells 1
or 15 days after administering BrdU (Fig. 1). The cell counts in
the SGZ and granule cell layer of the dentate gyrus revealed that
there was 52.9% reduction in the cells that incorporated BrdU
cells in Prnp0/0 mice when compared with the Prnp+/+ animals
1 day after the last BrdU pulse. Moreover, a similar decrease in
the number of cells expressing PSA-NCAM (a marker for neuronal
lineage in the SGZ [46,47,48,49]) was also detected (Fig. 1A). To
determine whether the decrease in the numbers of BrdU-positive
cells affected neurogenesis in the dentate gyrus, we assessed the
incorporation of BrdU in cells that expressed the neuronal marker
NeuN 15 days after the last BrdU pulse (Fig. 1A-C). While the
proportion of cells that incorporated BrdU in Prnp0/0 mice was
32% lower than in Prnp+/+ mice, the Figure rose to 50.7% when
considering the cells expressing NeuN that had incorporated BrdU
(Fig. 1A). Thus, the absence of PrPc diminished the proliferation
of neuroprogenitor cells and/or neurogenesis in the adult dentate
gyrus. However, a more detailed analysis of the BrdU incorpo-
ration revealed a significant increase in cells that incorporated
BrdU outside the granular cell layer and in the SGZ of the dentate
gyrus of Prnp0/0 mice (Fig. 1D-E), and these BrdU-positive cells in
the molecular layer also expressed NG2 (Fig. 1F). Based on this
observation, we sought to determine the possible role of PrPc in
oligodendrocyte proliferation and differentiation, both in vitro and
in vivo.
PrPc is Expressed by OPCs in the Developing and
Perinatal Telencephalon
In the CNS, PrPc expression has been described in postmitotic
neurons and glial cells [44,50], as well as in isolated oligodendro-
cytes and myelin [51]. However, there is no strong evidence to
date that PrPc is expressed by OPCs and indeed, glial PrPc was not
detected in the brain of transgenic mice expressing PrPc-eGFP
under the Prnp promoter [52] or eGFP under the control of the
bovine Prnp gene promoter [53]. Unfortunately, PrPc is difficult to
localize in tissue sections and there are only a few non-commercial
antibodies available to detect PrPc (see [52] for technical details).
Accordingly, we performed several experiments to define PrPc
expression in OPCs. First, we used double immunofluorescence to
examine PrPc expression in cultured OPCs that express NG2 from
P0 postnatal Prnp+/+ brains (Fig. 2A-C). Subsequently, we
determined the expression of PrPc in Western blots of protein
extracts from cortical OPC obtained from postnatal mice (P0–P2)
and from the mouse embryonic ON (Fig. 2D,E). The
characteristic pattern of PrPc expression was detected in Western
blots of Prnp+/+ OPC extracts [54] but it was absent from extracts
from Prnp0/0 mice. Moreover, we determined PrPc expression in
NG2-positive cells differentiated from SVZ neurospheres and
maintained for 20 weeks as floating aggregates in the presence of
EGF and FGF-2 before differentiating for 7 days without growth
factors (Fig. 2F-I). As expected, NG2-positive cells from Prnp0/0-
derived SVZ neurospheres exhibited no PrPc staining (Fig. 2H-I).
The Proliferation of OPCs is Stronger in ON Explants from
Prnp0/0 Embryos
We next analyzed OPC proliferation in embryonic ON explants
from Prnp0/0 and Prnp+/+ embryos (Fig. 3). At the developmental
stages studied, most of the cells populating the ON were
proliferating (Nestin-positive) oligodendrocyte precursors (Olig2-
positive). To study these two populations quantitatively, we
analyzed ON protein extracts in Western blots, which revealed
that more Nestin and Olig2 were found in the Prnp0/0 ON than in
the corresponding Prnp+/+ extracts (Fig. 3A). When ON explants
from the two genotypes were cultured on collagen matrices and
incubated with BrdU (see methods), no astrocytes migrated from
the explants and only OPCs identified as A2B5-positive cells
migrate radially from the explants [33,34,55] (Fig. 3B,C). Indeed,
more cells incorporated BrdU in the Prnp0/0 explants than in those
from Prnp+/+ mice (Fig. 3D,E), and after A2B5 immunostaining,
Prnp+/+ OPCs clearly migrated further from the explants
(Fig. 3F,G). To corroborate these observations, we counted the
number of double-labeled (A2B5-BrdU) cells in four quadrants
(200 mm2, yellow squares in Fig. 3H,I). Cell counts in randomly
selected quadrants of Prnp0/0 cultures revealed a 23% increase in
the number of A2B5 expressing cells that had incorporated BrdU
than in the Prnp+/+ cultures (Fig. 3I). By contrast, there was a 31%
decrease in the distance migrated by Prnp0/0 derived OPCs when
compared with Prnp+/+ OPCs (Fig. 3J).These data revealed a clear
correlation between the proliferation and migratory potential in
OPCs from Prnp0/0 ON explants, with higher proliferation
associated with lower migration. Indeed, Prnp+/+ OPCs displayed
weaker proliferative activity but increased migration. These
findings suggest that in three dimensional hydrogels, PrPc
decreased the proliferation and increased the migratory properties
of ON-derived oligodendrocytes.
The Absence of PrPc in Isolated Cortical OPCs Augments
Proliferation and Delays Differentiation
OPC primary cultures were established from Prnp0/0 and
Prnp+/+ mouse pups (P0-P2) as described previously [36], and the
presence of OPCs (identified as NG2-positive cells) growing over
an astrocyte monolayer was determined by dual immunohisto-
chemistry (Fig. 4A). After 3 DIV, there were many ramified
oligodendrocytes in cultures derived from Prnp+/+ mice, which
were clearly visible by phase contrast microscopy (Fig. 4B,D).
By contrast, Prnp0/0 cultures contained unramified bipolar cells
Oligodendrocyte Proliferation & Maturation by PrPc
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(Fig. 4C,E). To define the putative delay in OPC maturation in
these cultures, we performed dual immunohistochemistry 5 DIV
after the addition of SFM medium to examine markers of
different stages of oligodendrocyte maturation: Olig2, CNPase
(Fig. 4F-K) and MBP (Fig. 4M,N). Prnp0/0 cultures contained
fewer double-labeled (CNPase-Olig2) oligodendrocytes than
Prnp+/+ cultures, in which ramified double-labeled oligodendro-
cytes were frequently observed (Fig. 4F-L), and there was a 2.6-
fold increase in CNPase-positive cells (123 6 13 cells/mm2) in
the Prnp+/+ cultures with respect to the Prnp0/0 cultures (47.6 6
11 cells/mm2). Conversely, the number of Olig2 cells was 3.72-
fold greater in primary Prnp0/0 versus Prnp+/+ cultures (3,033 6
136 vs 816 6 113 cells/mm2, respectively: Fig. 4L).
When we studied markers of further differentiation, such as
MBP, Prnp0/0 derived oligodendrocyte cultures exhibited milder
MBP staining than Prnp+/+ cultures in which several multipolar
cells displayed considerable MBP staining (Fig. 4M,N). Taken
together, these results suggest that there is a delay in
oligodendrocyte differentiation in Prnp0/0 cultures. To corrobo-
rate these findings, we assessed the expression of oligodendrocyte
markers in mRNA extracted from oligodendrocytes in mixed
cultures after 5DIV in SFM and we found that Olig2, Sox10 and
Nkx2.2 were mildly up-regulated in oligodendrocytes derived
from Prnp0/0 cultures (Fig. 4O). However, when markers of
different stages of oligodendrocyte differentiation were analyzed
there was an up-regulation of NG2 in Prnp0/0 cultures while other
markers of maturation were down-regulated, such as Sox17,
CNPase and APC (Fig. 4O). These data suggest that the absence
of PrPc delays oligodendrocyte differentiation in vitro. Finally, we
analyzed the differential expression cyclin-dependent kinase 2
(cdk2), a marker of the cell cycle that controls the progression of
oligodendrocytes through the cell cycle and their differentiation
[56,57]. Cdk2 expression was significantly up-regulated in
oligodendrocytes derived from Prnp0/0 cultures, consistent with
the immature oligodendrocyte phenotype observed in
Prnp0/0 cultures.
Given that we were working with mixed cultures and since
astrocytes also express PrPc (Fig. S1), we examined whether
astrocyte conditioned media from Prnp+/+ astrocytes influenced
OPC differentiation in Prnp0/0 cultures and vice versa. Results
showed a lower percentage of CNPase/Olig2 cells in Prnp0/0 OPC
cultures than in Prnp+/+ irrespective of the amount of the added
astrocyte conditioned media (Fig. S1). To further rule out the
potential influence of astrocytes on OPC differentiation, isolated
OPCs from Prnp0/0 and Prnp+/+ mice were maintained in SFM
medium (see methods). After 5 DIV, OPCs derived from Prnp+/+
mice again displayed more CNPase-positive ramifications than
those from Prnp0/0 mice (Fig. 4P,Q). Moreover, fewer oligoden-
Figure 1. Low SGZ proliferation and neurogenesis in the dentate gyrus of adult Prnp0/0 mice correlate with high numbers of double
labeled NG2-BrdU cells in the molecular layer. A) Left: Quantification of the number of PSA-NCAM-positive and BrdU-positive cells in dentate
gyrus sections from Prnp+/+ and Prnp0/0 mice one day after BrdU-labeling. Right: Quantification of the number of BrdU-positive and BrdU/NeuN-
positive cells per section in the dentate gyrus 15 days after administering the last BrdU pulse. Values represent the mean 6 standard deviation and
the asterisks indicate statistical significance (P , 0.01, Students t-test). B-C) Representative photomicrographs showing the suprapyramidal region of
the adult dentate gyrus of 2 month old Prnp+/+ (B) and Prnp0/0 (C) mice injected with BrdU 15 days prior to sacrifice. Sections were incubated with
antibodies for NeuN and BrdU and the arrows indicate newborn neurons in the dentate gyrus. The fluorochrome used in each case is indicated in the
Figure. D-E) Representative low power photomicrographs of the dentate gyrus of 2 month old Prnp+/+ (D) and Prnp0/0 (E) mice injected with BrdU
1 day prior to sacrifice. Note the decrease in the number of cells that incorporate BrdU (arrows) in the subgranular zone of Prnp0/0 compared to
Prnp+/+ mice. By contrast, numerous BrdU-positive cells (arrowheads) can be seen in the molecular layer of Prnp0/0 than in Prnp+/+ mice. F) Example of
a double-labeled BrdU/NG2 cells in the molecular layer of Prnp0/0 mice. This image was obtained on an Olympus confocal microscope and processed
with Imaris Silicon Graphics software to obtain the orthogonal 3D Z-axis projections. Orthogonal projections are shown on the right (y-axis) and at
the bottom (x-axis). Abbreviations: DG: dentate gyrus: GCL: granule cell layer; ML: molecular layer; H: Hilus; SGZ: subgranular zone. Scale bars: B =
50 mm also applies to C. D = 200 mm also applies to E; F = 25 mm.
doi:10.1371/journal.pone.0033872.g001
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drocytes were double-labeled (CNPase/Olig2) in Prnp0/0 cultures
compared to Prnp+/+ ones (Fig. S2). To corroborate these findings,
we analyzed the mRNA isolated from these oligodendrocytes at 0
and 5 DIV in SFM. We observed similar tendencies in these
cultures to the mixed cultures and again, oligodendrocyte markers
were up-regulated in knockout mice (Olig2 and NG2) while
differentiation markers were downregulated, such as Sox17 (Fig.
S2). Together, these data confirm that the differences in the
oligodendrocyte differentiation in absence of PrPC are not
mediated by astroglial cells.
Olig2- and NG2-positive Cells are More Abundant in
Prnp0/0 than in Prnp+/+ Mice at Perinatal and Adult Stages
When we next investigated the presence of OPCs during
perinatal development, we found that Olig2-immunoreactive cells
that migrated tangentially from subpalial regions were more
abundant (2.5-fold) in the neocortex of Prnp0/0 than in Prnp+/+
embryos (E16.5: Fig. 5A-D,O). Indeed, there was an increase in
cells expressing Olig2 and NG2 (Fig. 5P) in sections of the parietal
cortex of adult Prnp0/0 versus Prnp+/+ mice (Fig. 5E,F,J,K,H,M).
Moreover, these results correlated with the 1.44- and 1.35-fold
increase in Olig2 and NG2 mRNA in this region, as determined by
RT-qPCR (Fig. S3). Nissl counterstaining revealed no differences
between Prnp+/+ and Prnp0/0 mice in the organization of the
distinct layers in the adult cortex (Fig. 5G,L). Moreover, in situ
hybridization to study the expression of the myelin-associated
glycoprotein (MAG), identifying mature myelinating oligodendro-
cytes, revealed no significant changes in the neocortex
(Fig. 5I,N,Q), cingular cortex or the white matter of Prnp0/0
mice (Fig. 6A-C). Accordingly, myelination did not appear to be
affected by the absence of Prnp. Indeed, no significant differences
were detected between the two genotypes in terms of the amount
of total MAG or myelin basic protein (MBP) in adult cortical
(Fig. 6D) and spinal cord extracts (Fig. 6E). In addition, electron
microscopy revealed no alterations to the myelin sheaths in the
cortical white matter due to the loss of Prnp (Fig. 6F-I). In
conclusion, our results indicate an increase in the number of NG2-
and Olig2-positive cells in the neocortex of Prnp0/0 mice, which
were not correlated with defective myelination. These results are
consistent with the normal myelin content and structure described
previously in the CNS of Prnp0/0 mice (see Introduction).
The Number of NG2-positive Cycling Cells Increased in
the Neocortex of Adult Prnp0/0 Mice
We extended our studies on BrdU accumulation and examined
the effects of pulse labeling in adult mice. One day after the last
BrdU pulse, more cells had incorporated BrdU in all the cortical
areas and subcortical regions of adult Prnp0/0 mice than in Prnp+/+
mice. We also observed more cells that incorporated BrdU in all
layers of the parietal cortex in Prnp0/0 mice (43.85 6 4.4 as
opposed to 29.02 6 2.1 cells per 1.5 mm2 in Prnp+/+ mice:
Fig. 6J,K). Most of the cycling cells in the neural parenchyma that
Figure 2. PrPc is expressed in oligodendrocyte precursor cells. A-C) High magnification immunofluorescence images of double-labeled
(NG2-PrPc) cells in primary OPC cultures. D) PrPc detection in Western blots of brain extracts from P0 Prnp+/+ mice probed with the SAF61 antibody
(lane 1) and extracts from primary postnatal oligodendrocyte cultures of Prnp+/+ and Prnp0/0 mice (lanes 2 and 3 respectively). E) PrPc detection in
Western blots of embryonic mice ONs (E16.5) from Prnp+/+ (lane 1) and Prnp0/0 mice (lane 2) probed with the SAF61 antibody. No PrPc was detected in
ONs from Prnp0/0 mice. F-I) Immunofluorescence images of Prnp0/0 (F-G) and Prnp+/+ (H-I) SVZ neurospheres after differentiation, demonstrating the
ability of both genotypes to differentiate into NG2-positive cells. No PrPc expression was detected in NG2-positive cells in Prnp0/0 neurospheres. Scale
bars: A = 25 mm also applies to B-C; F = 50 mm also applies to G-I.
doi:10.1371/journal.pone.0033872.g002
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Figure 3. The absence PrPc increases OPC proliferation in cultured embryonic ONs. A) Western blots of embryonic ONs (E16.5) from
Prnp0/0 and Prnp+/+ mice probed for Nestin and Olig2. Expression of both proteins was increased in Prnp0/0 versus Prnp+/+ ONs. B-C) Representative
immunofluorescence images of a 2 DIV ON explant culture from Prnp+/+ mice in three dimensional collagen matrices after staining with anti-AB25
and counterstaining with DAPI. Cells that migrated radially were identified as OPCs by the expression of the A2B5 epitope (see also lower box). D-G)
Immunofluorescence photomicrographs of 2 DIV ON explant cultures from Prnp (D-E) and Prnp0/0 (F-G) mice in three dimensional matrices after
double staining with anti-BrdU and anti-A2B5. H) Scheme illustrating the method to quantify A2B5 and BrdU staining in explant cultures. Yellow
boxes to quantify each quadrant are shown. I) Histogram showing relative percentage of A2B5 and BrdU-positive cells in Prnp0/0 and Prnp+/+ mice.
The absence of PrPc significantly increased the number of BrdU-labeled OPCs. J) Quantification of the maximal distance migrated by OPCs in ON
explants. Prnp+/+ OPCs migrated significantly further than their Prnp0/0 counterparts. Values in I and J represent the mean 6 standard deviation, and
the asterisks indicate statistical significance (P , 0.01, Students t-test). Scale bars: in B and D = 200 mm also apply to A, and E-G, respectively.
doi:10.1371/journal.pone.0033872.g003
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Figure 4. Cultured Prnp0/0 oligodendrocytes remain in an undifferentiated state for longer than the Prnp+/+ controls. A) Low power
photomicrograph of a primary Prnp+/+ mixed culture showing NG2-positive oligodendrocytes (arrows) grown and differentiated over a GFAP-positive
astrocyte monolayer. B-C) Phase contrast (PhC) images of a Prnp+/+ (B) and Prnp0/0 (C) primary oligodendrocyte mixed cultures showing the
morphology after 3 days in SFM. Numerous ramified oligodendrocytes (arrows in B) can be seen in Prnp0/0-derived cultures, in contrast to the bipolar
oligodendrocyte morphologies (arrowheads in C) seen over the astrocyte monolayer (asterisk in B and C). D-E) High magnification images of B and C
showing the greater ramification (arrows) of Prnp+/+ versus Prnp0/0 (arrowheads) oligodendrocytes. F-K) Immunofluorescence images of Olig2 (F,I)
and CNPase (G,J) expression in mixed cultures (5 days in SFM) derived from Prnp+/+ and Prnp0/0 mice. Cultures were counterstained with DAPI and the
arrows indicate the CNPase-Olig2-positive cells in both cultures. Note the absence of double labeled (CNPase/Olig2) cells in Prnp0/0 derived cultures.
L) Histogram illustrating the mean number of Olig2 and CNPase cells per mm2 in cultures of both genotypes. Values represent mean 6 standard
deviation and the asterisks indicate statistical significance (P , 0.01 Students t-test). M-N) MBP labeling in Prnp+/+ (M) and Prnp0/0 (N) in mixed
cultures after 5 days in SFM. O) Histogram showing RT-qPCR analysis of RNA samples extracted from Prnp+/+ and Prnp0/0 purified oligodendrocytes
Oligodendrocyte Proliferation & Maturation by PrPc
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e33872
incorporated BrdU expressed NG2 (35.886 4.1 and 24.96 1.7 in
Prnp0/0 and Prnp+/+ mice, respectively: Fig. 6L), and these cells
(NG2-BrdU) were often arranged in small clusters or pairs
(Fig. 6M). However, 15 days after the last BrdU pulse (4 +
15 days after the first pulse), there were no significant differences
between Prnp0/0 and Prnp+/+ mice in terms of the number of cells
that had incorporated BrdU (5.1 6 0.7 vs. 5.6 6 0.8, respectively:
Fig. 6N). These data suggest that the initial overproduction of
BrdU labeled OPCs was subsequently attenuated by cell death.
Indeed, when we assessed the apoptotic cell death among surplus
NG2 cells using the TUNEL assay, some double-labeled NG2-
TUNEL-positive cells were observed in the Prnp0/0 parietal cortex
(Fig. 6O) but not in the sections of Prnp+/+ mice. After
quantification, we observed a slight increase in the number of
NG2/TUNEL cells in Prnp0/0 mice when compared to the wild-
type animals (Fig. S4). Although a direct correlation cannot be
established since Prnp0/0 cells are very sensitive to serum
withdrawal, a similar increase in the number of apoptotic cells
was also observed in the Prnp0/0 cultures in vitro (Fig. S4).
Discussion
Despite numerous studies into the role of PrPc and its
pathogenic isoform in transmissible spongiform encephalopathies
(TSEs), its function in healthy mammalian neural and non-
neuronal cells remains unclear. Opposing effects of PrPc
expression on cell proliferation have been reported and there is
considerable variation in the relative expression of this protein in
different proliferating cell types. For example, murine and bovine
PrPc is expressed strongly in proliferating cells such as hemato-
poietic stem cells, spermatogonia and lymphocytes [58,59,60,61],
whereas it is absent in other proliferating cells such as neural stem
cells in the SVZ [44] or gut [27]. Taken together, it appears that
PrPc expression may modulate the cell cycle and proliferation in a
cell specific manner, as demonstrated here. Indeed, we showed
that PrPc plays distinct roles in the proliferation of SGZ cells and
OPCs. We examined the effect of Prnp gene expression on
oligodendrocyte differentiation in detail and we demonstrated that
the absence of PrPc in OPCs increases their rate of proliferation,
strongly implicating PrPc expression in oligodendrocyte differen-
tiation. This finding is consistent with previous reports of higher
proliferative rates and shorter duplication times in neural cell lines
derived from Prnp0/0 mice when compared with those expressing
PrPc [62].
Our results demonstrate that OPCs from the embryonic ON
proliferate more in the absence of PrPc, both in perinatal stages
and in the adult neuronal parenchyma. However, these effects are
cell-specific and cannot be generalized to other cell types. For
example, treatment with specific antibodies against PrPc inhibits
the proliferation of human T lymphocytes after they are activated
[63], while re-expression of the Prnp gene in splenocytes derived
from Prnp0/0 mice restores their proliferative potential [64].
Similar findings were described in gastric cell lines [65] and
epithelial cells [66], and human embryonic stem cells (hESCs)
proliferation augments when they are incubated with recombinant
PrPc due to the down-regulation of PrPc [67]. Whether these
effects are mediated by the down-regulation of PrPc per se or
through specific PrPc-mediated intracellular signaling remains
unclear, as does the question regarding whether PrPc acts directly
(through its aggregation in lipid rafts) or indirectly (by binding to
cell receptors such as the laminin receptor (65) or to extracellular
factors like STI1 [45]). The identification of PrPc targets that
influence the cell cycle in specific cell types may shed light on these
issues. Interestingly, we found stronger cdk2 expression in cultured
OPCs derived from Prnp0/0 mice. Cdk2 participates in the G1-S
transition, and it is crucial for OPC proliferation and differenti-
ation [56,57]. In fact, contrasting patterns of cdk2 expression have
been described in proliferation and differentiation states [56].
However, we cannot rule out the possibility that extrinsic factors
modulate OPC proliferation and the increased expression of stress
markers in the Prnp0/0 mouse brain [38]. This increase in stress
may enhance the proliferation of OPCs in mutant mice as
described for other neural cells (e.g., microglia).
To the best of our knowledge, this is the first report of
oligodendrocyte differentiation in vitro in the absence of PrPc. The
absence of Prnp was correlated with an increase in the expression
of OPC markers (Olig2, Sox10, etc) and the down-regulation of
APC, CNPase and Sox17, particularly in cultured OPCs. Sox17
controls the transition from the proliferative to the myelinating
stage during oligodendrocyte development [68], and it modulates
the expression of myelin-associated genes like MBP [68]. Indeed,
we propose that the down-regulation of Sox17, together with that
of other regulators of cell fate, such as cdk2 (see above), is involved
in the delayed differentiation of Prnp0/0-derived OPCs in vitro,
although further studies will be necessary to confirm this
hypothesis. However, in a distinct model it was demonstrated
that the undifferentiated state was protracted in Prnp-deficient stem
cells after serum withdrawal, as determined by the expression of
Nestin as opposed to MAP2 protein [44]. Delayed maturation of
cerebellar granule cells was recently reported in Prnp0/0 mice,
mainly due to the protracted proliferation of granule cells during
the postnatal period [69], although normal motor behavior was
recovered around postnatal day 50. Similarly, a recent study
showed that cells PrPC expression contributes to neuritogenesis
[70].
Oligodendrocyte maturation is a complex process and com-
pensatory mechanisms may be active during development and in
adulthood. Such mechanisms could compensate for the absence of
PrPc, resulting in normal differentiation to mature myelinating
oligodendrocytes of a proportion of OPCs. This tentative
hypothesis may explain why despite the overproduction of OPCs,
oligodendrocytes that manage to ensheath the axon survive in
Prnp0/0 mice while those that fail degenerate. Oligodendrocyte
survival is regulated by their interaction with axons, which serves
to ensure that the correct number of oligodendrocytes is matched
to the surface of axons requiring ensheathment ([71], see also [72]
for discussion). Moreover, natural elimination of overproduced
OPCs by programmed cell death targeting OPCs that do not fully
mature has also been described [73]. In vivo, the direct contact of
OPCs with neurons and axonal tracts is maintained in a dynamic
manner, and their differentiation is dependent on intrinsic as well
as extrinsic cues provided by neurons (see [14,72,74] for recent
from mixed cultures after 5DIV in SFM (see methods for details). Data represent the mean induction of three independent experiments where GAPDH
was used as the reference gene. P-Q) Immunofluorescence images of double labeled CNPase-Olig2-positive cells in isolated OPCs cultures (5 days in
SFM, without astrocytes) derived from Prnp+/+ (P) and Prnp0/0 (Q) mice. Cultures were counterstained. In the Prnp0/0 cultures there were less
oligodendrocytes (Olig2-positive arrowheads) expressing CNPase with reduced ramifications (Q) compared to wild-type oligodendrocytes (P). Scale
bar: A = 50 mm; B = 50 mm also applies to C; D = 20 mm also applies to E; F = 50 mm also applies to G-K. M = 50 mm also applies to N. P = 40 mm
also applies to Q.
doi:10.1371/journal.pone.0033872.g004
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reviews). Thus, although large OPC populations are observed in
PrPc-deficient mice, it is feasible that similar numbers of OPCs
mature in Prnp0/0 and Prnp+/+ mice due to these neural factors and
axonal interactions (Fig. 7), neither of which influence this process
in vitro. Accordingly, overproduction of OPCs that do not mature
into myelinating oligodendrocytes through the appropriate
Figure 5. PrPc expression modulates the number of oligodendrocytes in the perinatal and adult neocortex. A-D) Low power
photomicrographs showing Olig2 expression in coronal sections of Prnp+/+ and Prnp0/0 embryonic (E16.5) brains. B,D) High magnification
photomicrographs of A and C. E-N) Low power photomicrographs showing a coronal brain section immunostained for NG2 (E and J), Olig2 (F, H, K
and M) and MAG. In situ hybridization (I and N) of the parietal cortex of adult Prnp+/+ (E-I) and Prnp0/0 mice (J-N). G and L are adjacent Nissl stained
sections to E and J. Note the increase in the number of NG2- and Olig2-positive cells in the Prnp0/0 neocortex compared to that of the Prnp+/+ mice. O)
Histogram showing the number of Olig2-positive cells in the embryonic neocortex of Prnp0/0 and Prnp+/+ mice. P) Histogram showing the number of
Olig2- and NG2-positive cells in the adult neocortex of Prnp0/0 and Prnp+/+ mice. The presence of Olig2- and NG2-positive cells increased significantly
in the knockout mice when compared with their Prnp+/+ counterparts. Q) Quantification of the number of MAG-positive cells in the adult cortex of
Prnp0/0 and Prnp+/+ mice, revealing no significant differences between these genotypes. Values represent the mean 6 standard deviation and the
asterisks indicate statistical significance (P , 0.01, Students t- test). Scale bars: A = 500 mm also applies to C; B = 200 mm also applies to D. E =
300 mm also applies to F,G and J-L; H = 100 mm also applies to I and M-N.
doi:10.1371/journal.pone.0033872.g005
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Figure 6. Adult Prnp0/0 mice exhibit normal myelination in the CNS. A-B) In situ hybridization of MAG in coronal sections from the brains of
adult Prnp+/+ and Prnp0/0 mice. C) Quantification of MAG-positive cells revealed no differences between genotypes in the corpus callosum or cingular
cortex. Values represent the mean 6 standard deviation and they were analyzed using the Student’s t-test. D-E) Western blots of brain extracts from
Prnp+/+ and Prnp0/0 mice showing no differences in the expression of the MAG and MBP myelin proteins between genotypes in neocortex (D) and
spinal cord (E). F, H) Lower magnification electron microscopy photomicrograph of Prnp+/+ and Prnp0/0 mice. G, I) Higher magnification of F and H,
respectively, showing no gross ultrastructural differences in the myelin sheaths of the corpus callosum. J-K) Representative photomicrographs of the
parietal cortex of Prnp+/+ (J) and Prnp0/0 (K) mice immunostained for BrdU 1 day after the last BrdU pulse. Slides were lightly counterstained with Nissl.
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neuronal-glia interactions may disappear due to cell death (Fig. 7).
Future studies will investigate the relationship between PrPc and
the expression of neuronal factors that modulate OPC differen-
tiation (e.g., PDGF-AA, neuregulins, Notch, etc.), which may be of
special interest when considering oligodendrocyte maturation in
demyelinating diseases and other myelopathies. In fact, the
absence of PrPc accelerates the onset of experimental autoimmune
encephalomyelitis (EAE) and exacerbates its devastating effects
[75,76]. Although warrant for further studies, the present data
suggest that in absence of PrPC, OPCs might remain in a more
protracted undifferentiated state that may negatively affect the
normal course of differentiation to myelinating oligodendrocytes in
the EAE model.
Numerous BrdU-positive cells can be seen in Prnp0/0 compared to wild-type (arrows in J and K) L) Quantification of BrdU incorporation and the
double-labeled BrdU-NG2-positive cells 1 day after the last BrdU pulse. Both populations increased in the parietal cortex of Prnp0/0 mice when
compared to Prnp+/+ mice. M) Photomicrograph of double-labeled BrdU-NG2 cells (arrows) in the parietal cortex of Prnp0/0 mice. Arrowheads indicate
non-BrdU NG2-positive cells. N) Quantification of BrdU-positive cells 15 days after the BrdU pulse (4 + 15 protocol). Values in (L) and (N) represent the
mean 6 standard deviation and the asterisks indicate statistical significance (P , 0.01, Student t-test). O) Photomicrograph showing double-labeled
NG2/TUNEL cells (arrows) in the Prnp0/0 parietal cortex, in which the arrowheads indicate non-NG2-TUNEL-positive cells. Abbreviations: DG: dentate
gyrus: GCL: granule cell layer; ML: molecular layer; H: Hilus; SGZ: subgranular zone. CC: corpus callosum; CGC: cingulate cortex; NC: neocortex. H:
hippocampus; Scale bars: A = 300 mm also applies to B; F: 2 mm also applies to H; G = 0.5 mm also applies to I; J and K = 100 mm. M = 50 mm and O
= 25 mm.
doi:10.1371/journal.pone.0033872.g006
Figure 7. A putative scheme of PrPc involvement in oligodendrocyte proliferation and maturation. A-B). Scheme summarizing the main
in vitro findings of the present study. The absence of PrPc in cultured OPCs from the ON and in the isolated cortical OPCs prolonged the proliferative
stage in these precursors, and the modification of intrinsic factors modulating cell proliferation and oligodendrocyte differentiation (e.g., Sox17, cdk2)
may delay their normal maturation. C-D) No differences in CNS myelination were observed between Prnp0/0 and Prnp+/+ mice, although increased
proliferation was observed in adult NG2 cells in Prnp0/0 mice. The putative changes in intrinsic factors are overcome by extrinsic (neuronal and
astroglial) factors to establish normal myelination. These extrinsic signals (e.g., PDGF-AA, FGF-2, IGF-1, NT-3 or CNTF) may help to control the proper
timing of OPC differentiation, ensuring adequate myelination and its maintenance. Surplus NG2 cells are eliminated by cell death in this balanced
system.
doi:10.1371/journal.pone.0033872.g007
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Supporting Information
Figure S1 Astrocytes do not affect oligodendrocyte
differentitation in vitro. A) Western blots of protein extracts
from astrocyte cultures from Prnp+/+ mice and total brain, probed
with GFAP and PrPc antibodies. B) Histogram showing the
percentage of CNPase/Olig2-positive cells in cultures of Prnp0/0
and Prnp+/+ mice in the presence of different amounts of
conditioned media collected from astrocyte cultures of the opposite
genotype (0, 25, 50 and 75% of conditioned media in SFM
medium). Values represent the mean 6 standard deviation and the
asterisks indicate statistical significance (P , 0.01, Student t-test). In
wild-type cultures there were no differences in differentiation in the
presence of Prnp0/0 astrocyte conditioned media, although there
were significantly more CNPase/Olig2-positive cells than in
knockout cultures. In Prnp0/0 OPCs cultures there were no
differences in differentiation in the presence of conditioned media
from wild-type astrocyte cultures.
(TIF)
Figure S2 Prnp0/0 oligodendrocytes were less differen-
tiated than the wild type oligodendrocytes in vitro. A)
Histogram showed the quantification of the CNPase/Olig2 double
labeled cells in cultures of isolated OPCs from Prnp0/0 and Prnp+/+
mice. Note that in Prnp0/0 cultures the proportion of mature
oligodendrocytes was lower. Values represent the mean 6
standard deviation, and the asterisks indicate statistical significance
(P , 0.01, Students t-test). B) Histogram showing RT-qPCR
analysis of RNA samples extracted from Prnp+/+ and Prnp0/0
purified oligodendrocytes after 0 and 5 DIV in SFM and without
astrocytes. The data represent the induction of three independent
experiments, with GAPDH used as the reference gene.
(TIF)
Figure S3 Prnp0/0 mice have increased levels of Olig2
and NG2mRNA than Prnp+/+ mice. Histogram showing RT-
qPCR analysis of RNA samples extracted from the adult Prnp+/+
and Prnp0/0 mouse cortex. Data represent the mean induction of
three independent experiments in which GAPDH was used as the
reference gene.
(TIF)
Figure S4 PrPc absence derived in OPCs less survival in
vivo and in vitro. A) Histogram showed the number of NG2/
TUNEL-positive cells in the neocortex of adult Prnp+/+ and Prnp0/0
mice. B) Histogram showed the number of double labeled Olig2/
TUNEL cells in isolated oligodendrocytes derived from Prnp+/+
and Prnp0/0 cultures. In both cases there were more apoptotic
oligodendrocytes in the absence of PrPc. Values in A and B
represent the mean 6 standard deviation, and the asterisks
indicate statistical significance (P , 0.01, Students t-test).
(TIF)
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